Abstract
Background/Objectives:
Subcutaneous adipose tissue grows rapidly during the first months of life. Lipoprotein lipase (LPL) has a quantitatively important function in adipose tissue fat accumulation and insulin-like growth factor-I (IGF-I) is a determinant of neonatal growth. Recent studies showed that LPL mass in non-heparinized serum (LPLm) was an index of LPL-mediated lipolysis of plasma triacylglycerol (TG). The objective was to know the influence of serum LPL and IGF-I on neonatal subcutaneous fat growth, especially on catch-up growth in low birth weight infants.
Subjects/Methods:
We included 47 healthy neonates (30 males, 17 females), including 7 small for gestational age. We measured serum LPLm and IGF-I concentrations at birth and 1 month, and analyzed those associations with subcutaneous fat accumulation.
Results:
Serum LPLm and IGF-I concentrations increased markedly during the first month, and positively correlated with the sum of skinfold thicknesses both at birth (r=0.573, P=0.0001; r=0.457, P=0.0035) and at 1 month (r=0.614, P<0.0001; r=0.787, P<0.0001, respectively). In addition, serum LPLm concentrations correlated inversely to very low-density lipoprotein (VLDL)-TG levels (r=−0.692, P<0.0001 at birth; r=−0.429, P=0.0052 at 1 month). Moreover, the birth weight Z-score had an inverse association with the postnatal changes in individual serum LPLm concentrations (r=−0.639, P<0.0001).
Conclusions:
Both serum LPLm and IGF-I concentrations were the determinants of subcutaneous fat accumulation during the fetal and neonatal periods. During this time, LPL-mediated lipolysis of VLDL-TG may be one of the major mechanisms of rapid growth in subcutaneous fat tissue. Moreover, LPL, as well as IGF-I, may contribute to catch-up growth in smaller neonates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM (1993). Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36, 62–67.
Gonzales A, Orlando RA (2007). Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutr Metab (Lond) 4, 22.
Häger A, Sjöstrm L, Arvidsson B, Björntorp P, Smith U (1977). Body fat and adipose tissue cellularity in infants: a longitudinal study. Metabolism 26, 607–615.
Hanyu O, Miida T, Kosuge K, Ito T, Soda S, Hirayama S et al. (2007). Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents. Clin Chim Acta 384, 118–123.
Kern PA, Martin RA, Carty J, Goldberg IJ, Ong JM (1990). Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia. J Lipid Res 31, 17–26.
Knittle JL, Timmers K, Ginsberg-Fellner F, Brown RE, Katz DP (1979). The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size. J Clin Invest 63, 239–245.
Kobayashi J, Hashimoto H, Fukamachi I, Tashiro J, Shirai K, Saito Y et al. (1993). Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin Chim Acta 216, 113–123.
Kobayashi J, Nohara A, Kawashiri MA, Inazu A, Koizumi J, Nakajima K et al. (2007). Serum lipoprotein lipase mass: clinical significance of its measurement. Clin Chim Acta 378, 7–12.
Okazaki M, Usui S, Ishigami M, Sakai N, Nakamura T, Matsuzawa Y et al. (2005). Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography. Arterioscler Thromb Vasc Biol 25, 578–584.
Ogawa Y, Iwamura I, Kuriya N, Nishida H, Takeuchi H, Takada M et al. (1998). Birth size standards by gestational age for Japanese neonates. Acta Neonatologica Japnonica 34, 624–632 (in Japanese).
Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB (2000). Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. Br Med J 320, 967–971.
Petridou E, Skalkidou A, Dessypris N, Kedikoglou S, Mantzoros C, Chroussos G et al. (2004). Growth velocity during the first postnatal week of life is not related to adiponectin or leptin. Paediatr Perinat Epidemiol 18, 395.
Saiki A, Oyama T, Endo K, Ebisuno M, Ohira M, Koide N et al. (2007). Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res Clin Pract 76, 93–101.
Sato K, Akiba Y, Chida Y, Takahashi K (1999). Lipoprotein hydrolysis and fat accumulation in chicken adipose tissues are reduced by chronic administration of lipoprotein lipase monoclonal antibodies. Poult Sci 78, 1286–1291.
Schmelzle HR, Fusch C (2002). Body fat in neonates and young infants: validation of skinfold thickness versus dual-energy X-ray absorptiometry. Am J Clin Nutr 76, 1096–1100.
Skalkidou A, Petridou E, Papathoma E, Salvanos H, Trichopoulos D (2003). Growth velocity during the first postnatal week of life is linked to a spurt of IGF-I effect. Paediatr Perinat Epidemiol 17, 281–286.
Soriguer Escofet FJ, Esteva de Antonio I, Tinahones FJ, Pareja A (1996). Adipose tissue fatty acids and size and number of fat cells from birth to 9 years of age—a cross-sectional study in 96 boys. Metabolism 45, 1395–1401.
Stettler N, Stallings VA, Troxel AB, Zhao J, Schinnar R, Nelson SE et al. (2005). Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation 111, 1897–1903.
Symonds ME, Mostyn A, Pearce S, Budge H, Stephenson T (2003). Endocrine and nutritional regulation of fetal adipose tissue development. J Endocrinol 179, 293–299.
Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T (1995). Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 15, 1086–1093.
Uthaya S, Thomas EL, Hamilton G, Doré CJ, Bell J, Modi N (2005). Altered adiposity after extremely preterm birth. Pediatr Res 57, 211–215.
Voshol PJ, Rensen PC, van Dijk KW, Romijn JA, Havekes LM (2009). Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: studies using genetically engineered mouse models. Biochim Biophys Acta 1791, 479–485.
Watanabe H, Miyashita Y, Murano T, Hiroh Y, Itoh Y, Shirai K (1999). Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias. Atherosclerosis 145, 45–50.
Zechner R, Strauss J, Frank S, Wagner E, Hofmann W, Kratky D et al. (2000). The role of lipoprotein lipase in adipose tissue development and metabolism. Int J Obes Relat Metab Disord 24, S53–S56.
Acknowledgements
We thank the medical and nursing staff of the ward for their assistance in this study. TO, SH, and ST designed the study; HM and TY supervised research; SM, AO, RY, and MM helped in data collection; KY and TO analyzed data; and KY and TO drafted the paper. This study was partly supported by Health and Labour Science Research Grants: Comprehensive Research on Cardiovascular Disease, 17160501, in Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Yoshikawa, K., Okada, T., Munakata, S. et al. Association between serum lipoprotein lipase mass concentration and subcutaneous fat accumulation during neonatal period. Eur J Clin Nutr 64, 447–453 (2010). https://doi.org/10.1038/ejcn.2010.25
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.25